MaaT Pharma Advances PHOENIX After Negative EMA Opinion
LYON, France — September 18, 2026 MaaT Pharma announced that the Committee for Medicinal Products for Human Use (CHMP)...
Regulatory Strategy
Advertisement
Dark Horse Consulting Expands China Cell Therapy Practice
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
Kalohexis Appoints Jeffrey Sherman to Board of Directors
Northbrook, Illinois, August,11, 2026 Kalohexis, Inc., a clinical-stage biotechnology company developing therapies that target the melanocortin system, has appointed...
Sanofi Ends Amlitelimab Development for Atopic Dermatitis
PARIS, France, July 24, 2026 Sanofi announced that it has discontinued the clinical development of amlitelimab for moderate-to-severe atopic...
Teva Expands Global Biosimilar Portfolio With Polpharma
TEL AVIV, Israel / ZUG, Switzerland | July 9, 2026 Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical...
Advertisements
DHCG and Altruist Partner to Advance Biologics in China
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
Dark Horse Consulting and KunTuo Partner to Accelerate CGT Trials
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
Dark Horse Consulting Group Partners with Porton Advanced for IITs
WALNUT CREEK, CA, USA & SUZHOU, CHINA, April 27, 2026 Dark Horse Consulting Group (DHCG) and Porton Advanced have...
Jupiter Neurosciences Aligns Capital With Clinical Growth
JUPITER, Fla., Feb. 23, 2026 — Jupiter Neurosciences, a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system...
Santé Ventures Raises $330M to Fund Early-Stage Life Sciences Innovation
AUSTIN, Texas, Feb. 2, 2026 — Early-stage investor Santé Ventures announced the successful close of its fifth and largest...
Advertisement
